Page 1
The Diagnostic Value in SARS-CoV-2 Infection (COVID-19) with COVID-19 IgG/lgM Rapid Test Kit
Jiangsu Provincial Center for Disease Control and Prevention
1. Experimental Purpose:Evaluate the diagnostic value in SARS-CoV-2 infection (COVID-19) with COVID-19 IgG/lgM Rapid Test Kit manufactured by Hangzhou Biotest Biotech Co.,Ltd. 2. Experimental Purpose:The study is a retrospective study on testing 100 samples from patients infected SARS-COV-2 (COVID-19) and 150 samples from the excluded cases collected by Jiangsu Provincial Center for Disease Control and Prevention from Feb.-Mar. 2020.
3. Experimental Material: 3.1 Product Information:COV2003001-T COVID-19 IgG/lgM Rapid Test Cassette (Colloidal gold)Product Lot#: COV2003001-T 3.2 Specimen Information:Definitive Diagnosed Cases of COVID-19 (100 Cases); Excluded Cases of COVID-19 (150 Cases). The Confirmed Cases and Excluded C according to “Diagnosis and Treatment Plan for Pneumonia Caused by issued by the National Health Commission of P.R. China.
4. Direction for Use:Read the entire manual and bring the test and specimens to reach room temperature (15-30°C)before use. Remove the test cassette from the sealed pouch and use it within one hour, especially temperature above 30°C or at high humidity.
1) Place the test cassette on a clean and level surface. Hold the dropper vertically, draw the specimen up to the Fill Line (approximately I 0μl), and transfer the specimen to the specimen well (S) of the test cassette, then add 2 drops of buffer (approximately 80μ1) to the buffer well (B). 2) Wait for the colored line(s) to appear. The test result should be read at 10 minutes. Do not interpret the result after 20 minutes
PREMIER BIOTECH, INC. | 723 KASOTA AVE SE, MINNEAPOLIS, MN 55414 | 888-686-9909 | WWW.PREMIERBIOTECH.COM
1 of 38
Page 2
5. Testing Method:For the confirmed COVID-19 infected patients or COVID-19 infection rule-out patients, evaluation on clinical sensitivity and specificity of in-vitro diagnostic kit should be carried out comparing to clinical diagnosis.
6. Testing Result:The 250 cases were confirmed according to “Diagnosis and Treatment Plan for Pneumonia Caused by Coronavirus Infection” issued by the ational Health Commission of P.R. China.
Positive Coincident Rate = 95/(95+5) X 100% =95%Negative Coincident Rate = 146/(146+4) X 100 % =97.3%Total Coincident Rate= (95+ 146)/(95+5+4+ 146) X 100 % =96.4%
At the same time, Kappa consistency test was performed on the test results, and the 95%confidence interval was selected. Kappa value lays between O and 1. The closer the Kappa value isto 1, the better the consistency is between the two diagnostic methods. Kappa = 0.925
7. Conclusion250 samples in total were tested, including 100 Definitive Diagnosed Cases and 150 excluded cases. 100
Positive Coincident Rate = 95/(95+5) X 100% = 95%Negative Coincident Rate = 146/(146+4) X 100 % = 97.3%Total Coincident Rate = (95+ 146)/(95+5+4+146) X 100 % = 96.4%
At the same time, Kappa consistency test was performed on the test results, and the 95% confidence interval was selected. Kappa value lays between O and 1. The closer the Kappa value is to 1, the better the consistency is between the two diagnostic methods. Kappa = 0.925
2 of 38
Page 3
7. Conclusion250 samples in total were tested, including 100 Definitive Diagnosed Cases and 150 excluded cases. 100 Definitive Diagnosed Cases were tested with the test of BIOTEST. 84 samples were detected as IgG positive and IgM positive. 2 samples were detected as IgG positive and IgM negative. 9 samples were detected as IgM positive and IgG negative. 5 samples were detected as IgG negative and IgM negative.
The clinical sensitivity for IgM test is 93.0% (93/100) and for IgG test is 100.0% (86/86). Note: The clinical sensitivity for IgG test is compared with INNOVITA Test. The clinical sensitivity in total is 95% (95/100).
150 Excluded Cases were tested with the test of BIOTEST. The clinical specificity for IgM test is 97.3% (146/150) and for IgG test is 99.3% (149/150).. The negative predict value is 97.3% (146/150).
The accuracy in total is 96.4% (241/250) for the COVID-19 IgG/IgM rapid test cassette.
Attachment 1: 100 Definitive Diagnosed Cases Test ResultsAttachment 2: 150 Excluded Cases Test Results
3 of 38
Page 4
Attachment 1: 100 Definitive Diagnosed Cases test results;
Experiment #No.
1 B1 49 DefinitiveSerum Male Regular
Diagnosis
2 B2 30 DefinitiveSerum Male Regular
Diagnosis
3 B3 59 DefinitiveSerum Male Regular
Diagnosis
4 B4 Femal 36 DefinitiveSerum Regular
Diagnosise
5 B5 43 Definitive
Serum Male Reg&Yal8Diagnosis
Feeble, Headache,Fever, Dry Cough,Expectoration.Chill
Chill, Fever, Dry Cough
Fever, Headache,Other, Expectoration
Fever. Chill.Expectoration,
Headache, FeebleFever, Expectoration,
Feeble
+ + +
+ + +
+ + +
+ + +
+ + +
+
+
+
+{
2020-02-28
2020-02-28
2020-02-28
+
2020-02-28
2020-02-28
SampleType
Sex Age DiagnosticResults
ClinicalSub-
Group
ClinicalSymptom
BIOTESTKit Results
IgM IgG
SampleAcquisition
Date
Nucleic Acid
Result
INNOVTAKit
Results
IgG
Page 5
6 B6 Femal 50 Definitive Serum Regular
e Diagnosis
7 B7 31 Definitive Serum Male Regular
Diagnosis
8 B8 34 Definitive Serum Male Regular
Diagnosis
9 B9 34 Definitive Serum Male Regular
Diagnosis
10 B10 61 Definitive Asympto Serum Male
Diagnosis matic Infection
11 B11 39 Definitive Serum Male Regular
Diagnosis
12 B12 23 Definitive Serum Male Regular
Diagnosis
5 / 38
+
+
Fever, Other, Headache
Fever, Dry Cough, Expectoration
+
Fever. Chill, Dry Cough
Fever +
.
Fever, Dry Cough, Muscle Pain
+
Fever. Chill, Feeble
+
Fever, Expectoration. Nasal Obstruction,
Running Nose, Feeble, Muscle Pain
+ +
+ +
. +
+ +
. .
+ +
+ +
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
Page 6
13 B13 30 Definitive Asympto Serum Male
Diagnosis matic Infection
14 B14 Femal 37 Definitive Asympto Serum
e Diagnosis matic Infection
15 B15 30 Definitive Asympto Serum Male
Diagnosis matic Infection
16 B16 Femal 42 Definitive Asympto Serum
e Diagnosis matic Infection
17 B17 Femal 33 Definitive Asympto Serum
e Diagnosis matic Infection
6/ 38
+ - +
Fever, Chill, Dry Cough
Pharyngalgia + + +
rRunning Nose - - -
Dry Cough, Expectoration,
+ + +
Feeble. Chill
Other + + +
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
+ 2020-02-28
Page 7
18 B18 1 Definitive Asympto Other + + + + 2020-02-28 Serum Male
Diagnosis matic Infection
Dry Cough, 19 B19 Femal 64 Definitive Asympto + + + + 2020-02-28
Serum Pharyngalgia e Diagnosis matic
Infection
20 B20 31 Definitive + + + + 2020-02-28 Serum Male Regular
Fever, Dry Cough, Headache
Diagnosis
21 B21 45 Definitive Asympto Expectoration + + + + 2020-02-28 Serum Male
Diagnosis matic Infection
22 B22 Femal 36 Definitive Asympto + - + + 2020-02-28 Serum
Fever, Dry Cough
Diagnosis matic Infection
+
1
23 B23 48 Definitive + + + ·�Q20'\�2- 8Serum Male Severe
Diagnosis
Chill, Headache,
Muscle Pain. Fever
1 I 38
Page 8
24 B24 33 Definitive Asympto Serum Male
Diagnosis matic
Infection
25 B25 25 Definitive Asympto Serum Male
Diagnosis matic
Infection
26 B26 38 Definitive Asympto Serum Male
Diagnosis matic Infection
27 B27 Femal 57 Definitive Asympto Serum
e Diagnosis matic
Infection
28 B28 Definitive 36 Serum Male Regular
Diagnosis
29 B29 47 Definitive Serum Male Regular
Diagnosis I
8/ 38
Dry Cough + + +
+ + +
Fever, Dry Cough
+ + +
Expectoration,
Running Nose
+ + +
Dry Cough, Other, Fever
+ + +
Fever, Dry Cough,
Chill
Expectoration + + +
+
+
+
+
+/.; -
2020-02-28
2020-02-28
2020-02-28
2020-02-28
+ 2020-02-28
2020-02-28
Page 9
30 B31 23 Definitive Fever + + + + 2020-03-01 Serum Male Regular
Diagnosis
31 B32 Femal 52 Definitive Asympto + + + + 2020-03-01 Serum
lExpectoration,
Running Nosee Diagnosis matic
Infection
32 B33 22 Definitive + + + + 2020-03-01 Serum Male Mild
Diagnosis
Fever. Headache.
Chill, Dry Cough
33 B34 Femal 51 Definitive Fever + + + + 2020-03-01 Serum Regular
e Diagnosis
34 B35 Femal 56 Definitive Asympto Other + + + + 2020-03-01 Serum
e Diagnosis matic
Infection
35 B36 31 Definitive + - - + 2020-02-26 Serum Male Regular
Diagnosis
Fever, Dry Cough,
Expectoration
Fever 36 B37 Femal 20 Definitive - - - +Serum Asympto
e Diagnosis matic
9 I 38
2020-02-29
Page 10
Infection
37 B38 Femal 20 Definitive Asympto Serum
e Diagnosis matic Infection
38 B39 23 Definitive Serum Male Regular
Diagnosis
39 B40 55 Definitive Asympto Serum Male
Diagnosis matic Infection
40 B41 66 Definitive Serum Male Regular
Diagnosis
41 B42 Femal 53 Definitive Serum Regular
e Diagnosis
42 B43 Femal 31 Definitive Serum Regular
e Diagnosis
43 B44 43 Serum Male Definitive Regular
10/ 38
Fever . . .
+ + +
Fever, Expectoration
Other + . .
+ + +
Fever, Dry Cough
+ + +
Fever, Expectoration
Fever + + +
Fever + + +
+
+
+
+
2020-03-02
2020-03-02
2020-03-01
2020-03-04
2020-03-04
2026-b3-o2J:-....._
2026-b3-o2J:-....._
+
+
Page 11
44
45
46
47
48
49
50
51
B45
B46
B47
B48
B49
B50
B51
B52
Serum
Serum
Serum
Serum
Serum
Serum
Serum
Femal
e
Male
Male
Male
Femal
e
Femal
e
Male
46
46
31
49
51
55
33
56
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Regular
Asympto
matic
Infection
Regular
Regular
Regular
Regular
Fever,
Expectoration
Other
Fever, Dry Cough,
Expectoration
Fever, Dry Cough
Dry Cough, Diarrhea
Fever
Mild
Fever, Dry Cough
11 / 38
+ + + + 2020-03-04
+ + + + 2020-03-04
+ + + + 2020-03-05
+ + + + 2020-03-05
+ + + + 2020-03-05
+ + + + 2020-03-05
+ + +
+ + +
+ 2020-03-05
+ 2020-03-05
Page 12
Serum Male Definitive Mild
Diagnosis
52 B53 29 Definitive Serum Male Regular
Diagnosis
53 B54 46 Definitive Asympto Serum Male
Diagnosis matic
Infection
54 B55 Femal 49 Definitive Asympto Serum
e Diagnosis matic
Infection
t
55 B56 59 Definitive Asympto Serum Male
Diagnosis matic
Infection
56 B57 Femal 12 Definitive Asympto Serum
e Diagnosis matic
Infection
12/ 38
Fever
+ - -Fever,
Expectoration
Other + + +
Other + + +
+ + +
Dry Cough,
Pharyngalgia
Other + + +
+
+
+
+
2020-03-05
2020-03-05
2020-03-05
2020-03-05
+ 2020-03-05
Page 13
57 B58
58 B59
59 B60
60 B61
61 B62
62 B63
63 B64
64 B65
Serum
Serum
Serum
Serum
Serum
Serum
Serum
Serum
Femal
e
Femal
e
Male
Male
Femal
e
51
6
27
31
31
52
Femal 49
e
Femal 61
e
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Definitive
Diagnosis
Regular
Mild
Regular
Regular
Regular
Regular
Fever, Dry Cough,
Expectoration,
Pharyngalgia
Other
Fever, Expectoration
Dry Cough
Fever, Expectoration
Fever,
Expectoration
Regular
Fever, Dry Cough,
Expectoration,
Vomitting, Diarrhea
Fever
Asympto
13 / 38
+ + + + 2020-03-05
+ + + + 2020-03-07
+ + + + 2020-03-08
+ + + + 2020-02-28
+ + + + 2020-02-28
+ + + + 2020-03-06
+ + +
+ + +
+ 2020-03-09
+ 2020-03-09
Page 14
matic Infection
65 B66 Femal 22 Definitive Asympto Serum
e Diagnosis matic Infection
66 B67 39 Definitive Asympto Serum Male
Diagnosis matic Infection
67 B68 48 Definitive Serum Male Regular
Diagnosis
68 B69 Femal 40 Definitive Serum Regular
e Diagnosis
69 B70 25 Definitive Asympto Serum Male
Diagnosis matic Infection
70 B71 57 Definitive Serum Male Mild
Diagnosis
14/ 38
Dry Cough + - -
+ + +
Fever, Dry Cough, Muscle Pain
Fever + + +
Feeble + + +
+ + +
Fever, Dry Cough
+ + +
Fever, Dry Cough
+
+
+
+
+
+
2020-03-09
2020-03-09
2020-03-09
2020-03-09
2020-03-09
2020-03-09
Page 15
71 B72 54 Definitive Asympto Serum Male
Diagnosis matic
Infection
72 B73 Femal 25 Definitive Asympto Serum
e Diagnosis matic
Infection
73 B74 56 Definitive Serum Male Regular
Diagnosis
74 B75 66 Definitive Serum Male Regular
Diagnosis
75 B76 Femal 53 Definitive Serum Regular
e Diagnosis
76 B77 Femal 31 Definitive Serum Regular
e Diagnosis
77 B78 43 Definitive Serum Male Regular
Diagnosis
15 / 38
;l't11h Other - - -
Dry Cough + + +
Expectoration + + +
+ + +
Fever, Dry Cough
+ + +
Fever, Expectoration
Fever + + +
Fever + + +
+ 2020-03-09
+ 2020-03-09
+ 2020-02-10
+ 2020-03-04
+ 2020-03-04
+ 2020-03-04
+ 2020-03-04
Page 16
78 879 57 Definitive Serum Male Regular
Diagnosis
79 880 Femal 31 Definitive Asympto Serum
e Diagnosis matic Infection
80 881 48 Definitive Serum Male Regular
Diagnosis
81 882 56 Definitive Serum Male Regular
Diagnosis
82 883 Femal 75 Definitive Serum Regular
e Diagnosis
83 884 31 Definitive Serum Male Regular
Diagnosis
84 885 Femal 31 Definitive Serum Regular
e Diagnosis
85 886 31 Serum Femal Definitive
16/ 38
Fever, Dry Cough, Chest
Distressdyspnea, Other
Other
Other
Expectoration
Other
Dry Cough
Fever, Expectoration
Other
+ + +
+ + +
+ + +
- + +
+ - -
+ + +
+ + +
+ + +
+
+
+
+
+
+
2020-03-03
2020-03-05
2020-02-11
2020-02-10
2020-02-12
2020-02-28
+ 2020-02-28
+ 2020-02-14
Page 17
e Diagnosis Asympto matic
Infection
86 B87 38 Definitive Serum Male Regular
Diagnosis
87 B88 25 Definitive Serum Male Regular
Diagnosis
88 B89 Femal 12 Definitive Asympto Serum
e Diagnosis matic Infection
89 B90 Femal 6 Definitive Serum Mild
e Diagnosis
90 B91 57 Definitive Serum Male Regular
Diagnosis
91 B92 Femal 25 Definitive Serum Regular
e Diagnosis
17 / 38
1Expectoration,¥RunningNose, fPharyngalgia ,
Fever
Fever
Other
Other
Fever. Dry Cough, Chest
Distressdyspnea,Other
Fever
+ + +
+ - -
+ + +
+ + +
+ + +
+ + +
+
+
+
+
+
2020-02-14
2020-02-28
2020-02-28
2020-02-10
2020-03-03 �\• ,.J. ""'·
2020-03-01
Page 18
92 B93 Femal 60 Definitive Serum
e Diagnosis
93 B94 Femal 56 Definitive Serum
e Diagnosis
94 B95 Femal 56 Definitive Serum
e Diagnosis
95 B96 Femal 65 Definitive Serum
e Diagnosis
96 B97 Femal 38 Definitive Serum
e Diagnosis
97 B98 Femal 67 Definitive Serum
e Diagnosis
Asympto Fever + + +
matic
Infection
Other + + +
Mild
Asympto uPharyngalgia + + +
matic
Infection
Asympto Fever + + +
matic
Infection
Asympto Other - + +
matic
Infection
�Other + + +
Asympto
18/ 38
+
+
+
+
+
2020-03-01
2020-03-01
2020-03-01
2020-03-01
+ 2020-03-01
2020-03-01
Page 19
matic Infection
98 B99 Femal 47 Definitive Asympto Serum
e Diagnosis matic Infection
99 B100 Femal 62 Definitive Asympto Serum
e Diagnosis matic Infection
100 B101 Femal 57 Definitive Serum Mild
e Diagnosis
19 / 38
Other + + +
Other + + +
+ + +
Fever, Dry Cough, Expectoration
+
+
2020-03-01
2020-03-01
+ 2020-03-01
Page 20
Attachment 2: 150 Excluded Cases test results;
2
3
4
5
6
Experiment No.
B102
B103
B104
B105
B106
B107
Sample Type
Male
Female
Male
Female
Male
Male
27
17
21
59
52
2
Serum
Serum
Serum
Serum
Serum
Serum
Diagnostic
Result
Exclusion
Exclusion
Exclusion
Exclusion
flF� Exclusion
Exclusion
20/ 38
Clinical Diagnosis
Background
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
Biotest Kit Result
lgM lgG
Nuclei cAcid Result
Sample Acquisition
Date
2020/2/4
2020/2/4
2020/2/4
2020/2/4
- - -Suspicious patient with the infections contact history
2020/2/4
2020/2/4 - - -Suspicious patient with the infections contact history
Page 21
7 B108 52
Female Serum Exclusion
8 B109 56
Male Serum Exclusion
9 B110 52
Female Serum Exclusion
10 B111 36
Male Serum Exclusion
11 B112 12
Male Serum Exclusion
12 B113 31
Female Serum Exclusion
13 B114 56
Male Serum Exclusion
14 B115 55
Female Serum Exclusion
21 / 38
- -
Suspicious patient with the
infections contact history
- -
Suspicious patient with
the infections contact
history - -Suspicious patient with
the infections contact
history - -
Suspicious patient with the
infections contact history
- -Suspicious patient with
the infections contact
history
- -Suspicious patient with
the infections contact
history
- -Suspicious patient with
the infections contact
history
- -
Suspicious patient with the
infections contact history
-
-
-
-
-
-
-
-
2020/2/4
2020/2/4
2020/2/4
2020/2/4
2020/2/4
2020/2/4
2020/2/4
2020/2/4
Page 22
15 B116 32
Female Serum Exclusion
Suspicious patient with the
infections contact history
16 B117 24
Female Serum Exclusion
Suspicious patient with the
infections contact history
17 B118 68
Male Serum Exclusion
Suspicious patient with the
infections contact history
18 B119 42
Male Serum Exclusion
Suspicious patient with the
infections contact history
19 B120 8
Female Serum Exclusion
Suspicious patient with
the infections contact
history
20 B121 35
Female Serum Exclusion
21 B122 71
Female Serum Exclusion
Suspicious patient with the
infections contact history
22 B123 43
Male Serum Exclusion Suspicious patient with the
infections contact history
22/ 38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- -
2020/2/5
2020/2/5
2020/2/5
2020/2/5
2020/2/5
2020/2/5
Suspicious patient with the
infections contact history
2020/2/5
2020/2/5 -
Page 23
23 B124 38
Female Serum Exclusion
Suspicious patient with the
infections contact history
24 B125 7
Male Serum Exclusion
Suspicious patient with the
infections contact history
25 B126 64
Male Serum Exclusion
Suspicious patient with the
infections contact history
26 B127 26
Male Serum Exclusion
Suspicious patient with the
infections contact history
27 B128 26
Male Serum Exclusion
Suspicious patient with the
infections contact history
28 B129 75
Female Serum Exclusion
Suspicious patient with the
infections contact history
29 B130 30
Male Serum Exclusion
Suspicious patient with the
infections contact history
30 B131 30
Male Serum Exclusion
Suspicious patient with the
infections contact history
23 / 38
- - -
- - -
- - -
- - -
- - -
+ + -
- - -
- - -
2020/2/5
2020/2/5
2020/2/5
2020/2/5
2020/2/5
2020/2/5
2n?n1.21c;
I ••. ;4, • 20�CJ1'7/f, '� •
Page 24
31 B132 30 Male Serum Exclusion
Suspicious patient with the
infections contact history
32 B133 34 Male Serum Exclusion
Suspicious patient with the
infections contact history
33 B134 30 Female Serum Exclusion
Suspicious patient with the
infections contact history
34 B135 27 Male Serum Exclusion
Suspicious patient with the
infections contact history
35 B136 15 Female Serum Exclusion
Suspicious patient with the
infections contact history
36 B137 31 Male Serum Exclusion
Suspicious patient with the
infections contact history
37 B138 16 Female Serum Exclusion
Suspicious patient with
the infections contact
history
38 B139 33 Female Serum Exclusion
Suspicious patient with
the infections contact
history
24/ 38
- -
+ -
- -
- -
- -
- -
- -
- -
-
-
-
-
-
-
- . -
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
Page 25
39 B140 34
Female Serum Exclusion
40 B141 33
Female Serum Exclusion
41 B142 20
Female Serum Exclusion
42 B143 35
Female Serum Exclusion
43 B144 30
Male Serum Exclusion
44 B145 26
Male Serum Exclusion
45 B146 35
Female Serum Exclusion
46 B147 27
Female Serum Exclusion
25 / 38
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
Page 26
47 B148 68 -
Male Serum Exclusion Suspicious patient with the
infections contact history
48 B149 61 -
Female Serum Exclusion Suspicious patient with the
infections contact history
49 B150 70 -
Female Serum Exclusion
50 B151 31 -
Male Serum Exclusion
Suspicious patient with the
infections contact history
51 B152 62 -
Female Serum Exclusion Suspicious patient with the
infections contact history
52 B153 63 -
Male Serum Exclusion Suspicious patient with the
infections contact history
53 B154 3 -
Male Serum Exclusion Suspicious patient with the
infections contact history
54 B155 9 -
Female Serum Exclusion Suspicious patient with the
infections contact history
26/ 38
- -
- -
- -
- -
- -
- -
- -
- -
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
Suspicious patient with the
infections contact history
2020/2/6
2020/2/6
Page 27
55 B156
56 B157
57 B158
58 B159
59 B160
60 B161
61 B162
62 B163
Male
Male
Male
Female
Male
Male
Male
Female
57
28
27
54
38
29
27
26
Serum
Serum
Serum
Serum
Serum
Serum
Serum
Serum
Exclusion
Exclusion
Exclusion
Exclusion
Exclusion
Exclusion
Exclusion
Exclusion
21 I 38
Suspicious patient with the infections contact history
Suspicious patient with the
infections contact history
Suspicious patient with the
infections contact history
Suspicious patient with the
infections contact history
Suspicious patient with the
infections contact history
Suspicious patient with the
infections contact history
Suspicious patient with the
infections contact history
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6 Suspicious patient with the
infections contact history
2020/2/6
Page 28
63 B164 29
Male Serum ExclusionSuspicious patient with theinfections contact history
64 B165 22
Male Serum ExclusionSuspicious patient with theinfections contact history
65 B166 59
Male Serum ExclusionSuspicious patient with theinfections contact history
66 B167 55
Female Serum ExclusionSuspicious patient with theinfections contact history
67 B168 22
Male Serum ExclusionSuspicious patient with theinfections contact history
68 B169 37
Female Serum ExclusionSuspicious patient with theinfections contact history
69 B170 72
Female Serum ExclusionSuspicious patient with theinfections contact history
70 B171 35
Male Serum ExclusionSuspicious patient with theinfections contact history
28/38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
Page 29
71 8172 80 - - - 2020/2/6 Male Serum Exclusion
Suspicious patient with the infections contact history
72 8173 20 + - - 2020/2/6 Female Serum Exclusion
Suspicious patient with the infections contact history
73 8174 25 - - - 2020/2/6 Female Serum Exclusion
Suspicious patient with the infections contact history
74 8175 33 - - - 2020/2/6 Male Serum Exclusion
Suspicious patient with the infections contact history
75 8176 34 - - - 2020/2/6 Male Serum Exclusion
Suspicious patient with the infections contact history
76 8177 42 - - - 2020/2/6 Male Serum Exclusion
Suspicious patient with the infections contact history
77 8178 64 - - - 2020/2/6 Female Serum Exclusion
Suspicious patient with the infections contact history
78 8179 86 :.-""2020/2/6'�- - -
Female Serum Exclusion Suspicious patient with the infections contact history
29 / 38
Page 30
79 B180 57 Male Serum Exclusion
80 B181 34 Female Serum Exclusion
Suspicious patient with the infections contact history
81 B182 53 Male Serum Exclusion
Suspicious patient with the infections contact history
82 B183 10 Female Serum Exclusion
Suspicious patient with the infections contact history
83 B184 35 Male Serum Exclusion
Suspicious patient with the infections contact history
84 B185 21 Female Serum Exclusion
Suspicious patient with the infections contact history
85 B186 44 Female Serum Exclusion
Suspicious patient with the infections contact history
86 B187 I
Female Serum Exclusion
30/ 38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
2020/2/6
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
2020/2/6
2020/2/6
Page 31
87 B188 31
Male Serum Exclusion
88 B189 33
Female Serum Exclusion
89 B190 3
Female Serum Exclusion
90 B191 50
Female Serum Exclusion
91 B192 6
Male Serum Exclusion
92 B193 8
Female Serum Exclusion
93 B194 10
Female Serum Exclusion
94 B195 30
Male Serum Exclusion
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -
Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -Suspicious patient with the
infections contact history
- - -
Suspicious patient with the
infections contact history
31 / 38
2020/2/6
2020/2/6
2020/2/6
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
Page 32
95 B196 30
Male Serum
96 B197 32
Female Serum
97 B198 56
Female Serum
98 B199 24
Female Serum
99 B200 10
Female Serum
100 B201 38
Male Serum
101 B202 35
Female Serum
102 B203 53
Female Serum
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
-
Exclusion Suspicious patient with the
infections contact history
32/ 38
-
-
-
-
-
-
-
-
- 2020/2/7
- 2020/2/7
- 2020/2/7
- 2020/2/7
- 2020/2/7
- 2020/2/7
- 2020/2/7
2020/2/7
Page 33
103 B204 46
Female Serum Exclusion Suspicious patient with the
infections contact history
104 B205 44
Female Serum Exclusion Suspicious patient with the
infections contact history
105 B206 78
Male Serum Exclusion Suspicious patient with the
infections contact history
106 B207 36
Male Serum Exclusion Suspicious patient with the
infections contact history
107 B208 34
Female Serum Exclusion Suspicious patient with the
infections contact history
108 B209 17
Female Serum Exclusion Suspicious patient with the
infections contact history
109 B210 10
Female Serum Exclusion Suspicious patient with the
infections contact history
110 B211 38
Male Serum Exclusion Suspicious patient with the
infections contact history
33 I 38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
�-· ·2q2012f1:.f:_
Page 34
111 B212 49Female Serum Exclusion
Suspicious patient with theinfections contact history
112 B213 49Male Serum Exclusion Suspicious patient with the
infections contact history
113 B214 39Female Serum Exclusion Suspicious patient with the
infections contact history
114 B215 9Female Serum Exclusion Suspicious patient with the
infections contact history
115 B216 24Female Serum Exclusion Suspicious patient with the
infections contact history
116 B217 29Female Serum Exclusion Suspicious patient with the
infections contact history
117 B218 44Male Serum Exclusion Suspicious patient with the
infections contact history
118 B219 13Male Serum Exclusion Suspicious patient with the
infections contact history
34/ 38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
Page 35
119 B220 41
Female Serum Exclusion
Suspicious patient with
the infections contact
history
120 B221 46
Male Serum Exclusion
Suspicious patient with
the infections contact
history
121 B222 47
Female Serum Exclusion
Suspicious patient with
the infections contact
history
122 B223 26
Male Serum Exclusion
Suspicious patient with
the infections contact
history
123 B224 41
Female Serum Exclusion
Suspicious patient with
the infections contact
history
124 B225 18
Male Serum Exclusion
Suspicious patient with
the infections contact
history
125 B226 43
Male Serum Exclusion
Suspicious patient with
the infections contact
history
126 B227 33
Male Serum Exclusion
Suspicious patient with
the infections contact
history
35 / 38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- . -
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
Page 36
127 B228 11 Male Serum Exclusion
128 B229 33 Female Serum Exclusion
129 B230 4 Female Serum Exclusion
130 B231 32 Female Serum Exclusion
131 B232 38 Male Serum Exclusion
132 B233 46 Male Serum Exclusion
133 B234 50 Female Serum Exclusion
134 B235 36 Male Serum Exclusion
36/ 38
- - - Suspicious patient with the infections contact
history - - - Suspicious patient with
the infections contact history
- - - Suspicious patient with the infections contact
history - - - Suspicious patient with
the infections contact history
- - - Suspicious patient with the infections contact
history - - - Suspicious patient with
the infections contact history
- - - Suspicious patient with the infections contact
history - - Suspicious patient with
the infections contact history
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
Page 37
135 B236 61
Female Serum Exclusion
Suspicious patient with
the infections contact
history
136 B237 75
Male Serum Exclusion
Suspicious patient with
the infections contact
history
137 B238 52
Female Serum Exclusion
Suspicious patient with
the infections contact
history
138 B239 75
Female Serum Exclusion
Suspicious patient with
the infections contact
history
139 B240 74
Male Serum Exclusion
Suspicious patient with
the infections contact
history
140 B241 44
Male Serum Exclusion
Suspicious patient with
the infections contact
history
141 B242 44
Female Serum Exclusion
Suspicious patient with
the infections contact
history
142 B243 22
Male Serum Exclusion
Suspicious patient with
the infections contact
history
37 I 38
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
Page 38
143 B244 65 - -
Female Serum Exclusion
144 B245 40 - -
Female Serum Exclusion
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
145 B246 40 - -
Male Serum Exclusion
146 B247 13 - -
Male Serum Exclusion
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
147 B248 4 +
-
Female Serum Exclusion Suspicious patient with the infections contact history
148 B249 44 - -Male Serum Exclusion
149 B250 18 - -
Male Serum Exclusion
150 B251 10 -
-
Female Serum Exclusion
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
Suspicious patient with the infections contact history
38/ 38
-
-
-
-
-
-
-
-
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/7
2020/2/8
2020/2/8
2020/2/8
